Literature DB >> 27932611

Kaposi's Sarcoma-Associated Herpesvirus Infection of Neurons in HIV-Positive Patients.

For Yue Tso1,2, Ashley Sawyer1,2, Eun Hee Kwon1,2, Victor Mudenda3, Dianne Langford4, You Zhou5, John West1,2, Charles Wood1,2.   

Abstract

Background: Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi sarcoma (KS), one of the leading cancers in human immunodeficiency virus (HIV)-infected patients in Zambia. KSHV was detected in the human central nervous system (CNS) by polymerase chain reaction (PCR) analysis, but tissue location and cell tropism for KSHV infection has not been established. Given the neurotropism exhibited by other herpesviruses and the frequent coinfection of HIV-positive individuals by KSHV, we sought to determine whether the central nervous system (CNS) can be infected by KSHV in HIV-positive Zambian individuals.
Methods: Postmortem brain tissue specimens were collected from individuals coinfected with KSHV and HIV. PCR and Southern blots were performed on DNA extracted from the brain tissue specimens to verify KSHV infection. Immunohistochemical analysis and immunofluorescent microscopy were used to localize and identify KSHV-infected cells. Tropism was further established by in vitro infection of primary human neurons with rKSHV.219.
Results: KSHV DNA was detected in the CNS from 4 of 11 HIV-positive individuals. Immunohistochemical analysis and immunofluorescent microscopy demonstrated that KSHV infected neurons and oligodendrocytes in parenchymal brain tissues. KSHV infection of neurons was confirmed by in vitro infection of primary human neurons with rKSHV.219.
Conclusion: Our study showed that KSHV infects human CNS-resident cells, primarily neurons, in HIV-positive Zambian individuals.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  HIV; Kaposi’s sarcoma-associated herpesvirus; central nervous system; neurons

Mesh:

Substances:

Year:  2017        PMID: 27932611      PMCID: PMC5853869          DOI: 10.1093/infdis/jiw545

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

Authors:  K A Staskus; R Sun; G Miller; P Racz; A Jaslowski; C Metroka; H Brett-Smith; A T Haase
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.

Authors:  Carrie B Coleman; Michael S Nealy; Scott A Tibbetts
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 3.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

Review 4.  Human herpes virus 8 in solid organ transplantation.

Authors:  Ella J Ariza-Heredia; Raymund R Razonable
Journal:  Transplantation       Date:  2011-10-27       Impact factor: 4.939

5.  Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus.

Authors:  Stephen J Dollery; Rey J Santiago-Crespo; Lela Kardava; Susan Moir; Edward A Berger
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

6.  Detection of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus DNA in CSF from persons infected with HIV who had neurological disease.

Authors:  N S Brink; Y Sharvell; M R Howard; J D Fox; M J Harrison; R F Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

7.  Primary gamma-herpesviral infection in Zambian children.

Authors:  Veenu Minhas; Brad P Brayfield; Kay L Crabtree; Chipepo Kankasa; Charles D Mitchell; Charles Wood
Journal:  BMC Infect Dis       Date:  2010-05-12       Impact factor: 3.090

Review 8.  Immune escape of γ-herpesviruses from adaptive immunity.

Authors:  Zhuting Hu; Edward J Usherwood
Journal:  Rev Med Virol       Date:  2014-04-15       Impact factor: 6.989

9.  Anatomical mapping of human herpesvirus reservoirs of infection.

Authors:  Tiansheng Chen; S David Hudnall
Journal:  Mod Pathol       Date:  2006-05       Impact factor: 7.842

10.  Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women.

Authors:  Alison M Elliott; Denise Whitby; Robert Newton; Katie Wakeham; Emily L Webb; Ismail Sebina; Lawrence Muhangi; Wendell Miley; W Thomas Johnson; Juliet Ndibazza
Journal:  Infect Agent Cancer       Date:  2011-09-30       Impact factor: 2.965

View more
  11 in total

1.  Human herpesvirus 8 DNA detection and variant analysis in patients with multiple sclerosis.

Authors:  Sayed Mahdi Marashi; Aliehossadat Mostafa; Zabihollah Shoja; Ahmad Nejati; Shohreh Shahmahmoodi; Yaghoub Mollaei-Kandelous; Mohammad Ali Sahraian; Somayeh Jalilvand
Journal:  Virusdisease       Date:  2018-08-10

2.  Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.

Authors:  Meilan He; Fan Cheng; Suzane Ramos da Silva; Brandon Tan; Océane Sorel; Marion Gruffaz; Tingting Li; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2019

Review 3.  Kaposi Sarcoma, a Trifecta of Pathogenic Mechanisms.

Authors:  Gabriela Rusu-Zota; Oana Mădălina Manole; Cristina Galeș; Elena Porumb-Andrese; Otilia Obadă; Cezar Valentin Mocanu
Journal:  Diagnostics (Basel)       Date:  2022-05-16

4.  Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties.

Authors:  Xiaohong Kong; Dongmei Li; Amirsalar Mansouri; Guobin Kang; Khalid Sayood; John West; Charles Wood
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

5.  RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism.

Authors:  For Yue Tso; Andrew V Kossenkov; Salum J Lidenge; Owen Ngalamika; John R Ngowi; Julius Mwaiselage; Jayamanna Wickramasinghe; Eun Hee Kwon; John T West; Paul M Lieberman; Charles Wood
Journal:  PLoS Pathog       Date:  2018-01-19       Impact factor: 6.823

6.  miR-34a-5p inhibits the malignant progression of KSHV-infected SH-SY5Y cells by targeting c-fos.

Authors:  Shuyuan Wu; Zhaofu Wu; Huiling Xu; Jinli Zhang; Wenyi Gu; Xiaohua Tan; Zemin Pan; Dongdong Cao; Dongmei Li; Lei Yang; Dongmei Li; Yuanming Pan
Journal:  PeerJ       Date:  2022-04-15       Impact factor: 3.061

7.  Biomolecular Fluorescence Complementation Profiling and Artificial Intelligence Structure Prediction of the Kaposi's Sarcoma-Associated Herpesvirus ORF18 and ORF30 Interaction.

Authors:  Yoshiko Maeda; Tadashi Watanabe; Taisuke Izumi; Kazushi Kuriyama; Shinji Ohno; Masahiro Fujimuro
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

Review 8.  Microglia at center stage: a comprehensive review about the versatile and unique residential macrophages of the central nervous system.

Authors:  Nils Lannes; Elisabeth Eppler; Samar Etemad; Peter Yotovski; Luis Filgueira
Journal:  Oncotarget       Date:  2017-12-11

9.  Lack of CD8+ T-cell co-localization with Kaposi's sarcoma-associated herpesvirus infected cells in Kaposi's sarcoma tumors.

Authors:  Salum J Lidenge; For Yue Tso; Owen Ngalamika; Jaydeep Kolape; John R Ngowi; Julius Mwaiselage; Charles Wood; John T West
Journal:  Oncotarget       Date:  2020-04-28

Review 10.  Flavonoids Target Human Herpesviruses That Infect the Nervous System: Mechanisms of Action and Therapeutic Insights.

Authors:  Miroslava Šudomová; Kateřina Berchová-Bímová; Alena Mazurakova; Dunja Šamec; Peter Kubatka; Sherif T S Hassan
Journal:  Viruses       Date:  2022-03-13       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.